A detailed history of Bvf Inc transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 1,239,470 shares of ANTX stock, worth $2.57 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,239,470
Previous 1,563,963 20.75%
Holding current value
$2.57 Million
Previous $32 Million 87.43%
% of portfolio
0.12%
Previous 0.84%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.78 - $21.53 $902,090 - $6.99 Million
-324,493 Reduced 20.75%
1,239,470 $4.03 Million
Q4 2022

Feb 14, 2023

SELL
$8.51 - $16.78 $448,494 - $884,339
-52,702 Reduced 3.26%
1,563,963 $14.9 Million
Q1 2022

May 16, 2022

BUY
$15.0 - $15.4 $24.2 Million - $24.9 Million
1,616,665 New
1,616,665 $24.4 Million

Others Institutions Holding ANTX

About AN2 Therapeutics, Inc.


  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $40.2M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.